Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Affinity peptides toward infliximab

Affinity peptides toward infliximab

US Patent 8822423 · Granted Sep 2, 2014

Estimated economic value: $42,295,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2025
Anti-PHF-tau antibodies and uses thereof2025
Chimeric antigen receptor system with adaptable receptor specificity2024
Neutralizing human anti-CD27 antibodies2023
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2023
Anti-CCL17 antibodies2022
Anti-CCL17 antibodies2022
Anti-CCL17 antibodies2020
Anti-CCL17 antibodies2020
GITR antibodies, methods, and uses2020
Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies2020
Anti-PHF-tau antibodies and uses thereof2020